Amitriptyline-Induced Constipation in Cynomolgus Monkeys Is Beneficial for the Evaluation of Laxative Efficacy
スポンサーリンク
概要
- 論文の詳細を見る
In an attempt to create an animal model of constipation in monkeys, amitriptyline was administered to cynomolgus monkeys at doses of 10-160 mg/kg body weight via a nasogastric tube. Normal control monkeys excreted feces frequently throughout the day. Monkeys treated with amitriptyline at doses of 10-40 mg/kg showed delays in feces excretion. The 60 mg/kg treated monkeys for the most part did not excrete feces during the 24 h after amitriptyline administration. The 80 and 120 mg/kg treated monkeys did not excrete feces until 24 h from administraiton of amitriptyline, and also showed prolonged crouching and lethargy. On the other hand, 160 mg/kg treated monkeys died within 24 h after administration. We therefore felt that the optimal dose for creating constipation in the monkeys was 60 mg/kg. We tested the appropriateness of this amitriptyline-induced constipated monkey model by observing the effects of a new laxative, the herbal medicine ND-10 and the commercially available laxative bisacodyl. Control monkeys (those not receiving ND-10 or bisacodyl) treated with 60 mg/kg amitriptyline did not excrete feces up to 32 h after amitriptyline administration in 2 of 3 monkeys. However, all monkeys treated with one tablet of ND-10 excreted feces. Also, in 4 monkeys administrated with bisacodyl, 3 excreted feces. In this study, we confirmed that constipation can be caused in cynomolgus monkeys by oral administration of amitriptyline. This model may also be useful for the evaluation of laxatives.
- 社団法人日本薬学会の論文
- 2000-05-01
著者
-
Koshitani Osamu
Naruto Research Institute Otsuka Pharmaceutical Factory Inc.
-
TSUSUMI Kazuhiko
Research and Development, Otsuka Pharmaceutical Factory, Inc.,
-
KISHIMOTO Sanae
Naruto Research Institute, Otsuka Pharmaceutical Factory, Inc.,
-
KOHRI Hideaki
Nutrition Research Institute, Otsuka Pharmaceutical Factory, Inc.,
-
Tsusumi Kazuhiko
Research And Development Otsuka Pharmaceutical Factory Inc.
-
Tsusumi Kazuhiko
大塚製薬
-
Kohri Hideaki
Nutrition Research Institute Otsuka Pharmaceutical Factory Inc.
-
Kishimoto Sanae
Naruto Research Institute Otsuka Pharmaceutical Factory Inc.
-
Tsutsumi Kazuhiko
Research And Development Otsuka Pharmaceutical Factory
関連論文
- Amitriptyline-Induced Constipation in Cynomolgus Monkeys Is Beneficial for the Evaluation of Laxative Efficacy
- P-56 Effects of particle size of fat emulsion on serum cholesterol and phospholipid levels in the rat.(Proceedings of the 27th Annual Meeting)
- Toxicity study in male rats infused intravenously L-cysteine.
- 22D-10-2 Changes in Hepatic Ammonia Metabolism in Rats with Thioacetamide-Induced Liver Cirrhosis.
- The Relationship between plasma High Density Lipoprotein Cholesterol Levels and Cholesteryl Ester Transfer Protein Activity in Six Species of Healthy Experimental Animals
- Streptozotocin-Induced Diabetic Cynomolgus Monkey Is a Model of Hypertriglyceridemia with Low High-Density Lipoprotein Cholesterol
- Effects of Various Amino Acids on Serum Transaminase Activities in Dogs.
- The Relationship between Lipoprotein Lipase Activity and Respiratory Quotient of Rats in Circadian Rhythms(Pharmacology)
- The Novel Analgesic Compound OT-7100 (5-n-Butyl-7-(3,4,5-trimethoxybenzoylamino)pyrazolo[1,5-a]pyrimidine) Attenuates Mechanical Nociceptive Responses in Animal Models of Acute and Peripheral Neuropathic Hyperalgesia